Scott A. Fulton

1.2k total citations
28 papers, 972 citations indexed

About

Scott A. Fulton is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Scott A. Fulton has authored 28 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Epidemiology and 13 papers in Immunology. Recurrent topics in Scott A. Fulton's work include Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (8 papers) and Immune Response and Inflammation (6 papers). Scott A. Fulton is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (8 papers) and Immune Response and Inflammation (6 papers). Scott A. Fulton collaborates with scholars based in United States, Canada and Greece. Scott A. Fulton's co-authors include W. Henry Boom, Scott M. Reba, Clifford V. Harding, Thomas D. Martin, Roxana E. Rojas, Jill M. Johnsen, Derek Sieburth, S F Wolf, David H. Canaday and Zahra Toossi and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

Scott A. Fulton

28 papers receiving 942 citations

Peers

Countries citing papers authored by Scott A. Fulton

Since Specialization

Citations

This map shows the geographic impact of Scott A. Fulton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Fulton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Fulton more than expected).

Fields of papers citing papers by Scott A. Fulton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott A. Fulton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Fulton. The network helps show where Scott A. Fulton may publish in the future.

Co-authorship network of co-authors of Scott A. Fulton

This figure shows the co-authorship network connecting the top 25 collaborators of Scott A. Fulton. A scholar is included among the top collaborators of Scott A. Fulton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott A. Fulton. Scott A. Fulton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigating and Treating a Corneal Ulcer Due to Extensively Drug-Resistant Pseudomonas aeruginosa 2023 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), Scott A. Fulton, Jennifer Furin, Nicholas Newman, Ahmed F. Omar, Laura J. Rojas, Steven H. Marshall, Mohamad Yasmin, Robert A. Bonomo	9
2	Dosing Colistimethate Every 8 h Results in Higher Plasma Concentrations of Active Colistin Than Every 12-Hourly Dosing without Increase in Nephrotoxicity: A Phase 1 Pharmacokinetics Trial in Healthy Adult Volunteers 2022 ·Antibiotics ·George A. Yendewa, J. McLeod Griffiss, (unknown), (unknown), Howard M. Proskin, Scott A. Fulton, Mary Ann O’Riordan, Charles L. Hoppel, Jeffrey L. Blumer, Robert A. Salata	5
3	Prehospital Ketamine Use for Rapid Sequence Intubation: Are Higher Doses Associated With Adverse Events? 2020 ·Air Medical Journal ·William B. Krebs, Howard A. Werman, (unknown), (unknown), (unknown), Michael Rodgers, Scott A. Fulton, (unknown), (unknown), Nancy Buderer, (unknown)	2
4	A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation 2019 ·Journal of Global Antimicrobial Resistance ·George A. Yendewa, J. McLeod Griffiss, Michael R. Jacobs, Scott A. Fulton, Mary Ann O’Riordan, (unknown), Howard M. Proskin, Peter Winkle, Robert A. Salata	14
5	Case Report: Postvaccination Anti–Myelin Oligodendrocyte Glycoprotein Neuromyelitis Optica Spectrum Disorder 2019 ·International Journal of MS Care ·(unknown), (unknown), (unknown), (unknown), Scott A. Fulton, Robert Hostoffer, Hesham Abboud	27
6	Chemokine (C-C Motif) Receptor 5 −2459 Genotype in Patients Receiving Highly Active Antiretroviral Therapy: Race-Specific Influence on Virologic Success 2011 ·The Journal of Infectious Diseases ·Rajeev K. Mehlotra, Vinay K. Cheruvu, (unknown), (unknown), Michael M. Lederman, Robert A. Salata, Barbara Gripshover, Grace A. McComsey, Michelle V. Lisgaris, Scott A. Fulton, Carlos S. Subauste, Richard J. Jurevic, Chantal Guillemette, Peter A. Zimmerman, Benigno Rodríguez	9
7	Mycobacterium bovis BCG decreases MHC-II expression in vivo on murine lung macrophages and dendritic cells during aerosol infection 2008 ·Cellular Immunology ·Nicole Pecora, Scott A. Fulton, Scott M. Reba, Michael G. Drage, Daimon P. Simmons, (unknown), W. Henry Boom, Clifford V. Harding	52
8	Modulation of Naive CD4⁺T-Cell Responses to an Airway Antigen during Pulmonary Mycobacterial Infection 2007 ·Infection and Immunity ·(unknown), Scott A. Fulton, Scott M. Reba, Clifford V. Harding, W. Henry Boom	12
9	Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon‐γ 2006 ·Immunology ·Ana Paula Junqueira‐Kipnis, Randall J. Basaraba, Veronica Gruppo, Gopinath S. Palanisamy, Oliver C. Turner, Tsungda Hsu, William R. Jacobs, Scott A. Fulton, Scott M. Reba, W. Henry Boom, Ian M. Orme	30
10	Interferon‐αβ mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette–Guérin infection 2006 ·Immunology ·John Kuchtey, Scott A. Fulton, Scott M. Reba, Clifford V. Harding, W. Henry Boom	30
11	Gender differences in human immunodeficiency virus (HIV) RNA and CD4 cell counts among new entrants to HIV care 2006 ·Clinical Microbiology and Infection ·(unknown), Benigno Rodríguez, Grace A. McComsey, Barbara Gripshover, Robert A. Salata, (unknown), Michelle V. Lisgaris, Scott A. Fulton, Michael M. Lederman	14
12	The Purinergic P2X7 Receptor Is Not Required for Control of Pulmonary Mycobacterium tuberculosis Infection 2005 ·Infection and Immunity ·Amy Myers, Brandon Eilertson, Scott A. Fulton, JoAnne L. Flynn, David H. Canaday	24
13	Long-Term Prophylaxis of Spontaneous Bacterial Peritonitis in Patients with Cirrhosis 2005 ·Annals of Pharmacotherapy ·(unknown), (unknown), (unknown), Scott A. Fulton	7
14	Human immunity to M. tuberculosis: T cell subsets and antigen processing 2003 ·Tuberculosis ·W. Henry Boom, David H. Canaday, Scott A. Fulton, Adam J. Gehring, Roxana E. Rojas, Marta Torres	123
15	Neutrophil-Mediated Mycobacteriocidal Immunity in the Lung duringMycobacterium bovisBCG Infection in C57BL/6 Mice 2002 ·Infection and Immunity ·Scott A. Fulton, Scott M. Reba, Thomas D. Martin, W. Henry Boom	77
16	Completion of upper endoscopic procedures despite paradoxical reaction to midazolam: a role for flumazenil? 2000 ·The American Journal of Gastroenterology ·Scott A. Fulton, Kevin D. Mullen	41
17	Pulmonary Immune Responses during Primary Mycobacterium bovis – Calmette-Guerin Bacillus Infection in C57Bl/6 Mice 2000 ·American Journal of Respiratory Cell and Molecular Biology ·Scott A. Fulton, Thomas D. Martin, Raymond W. Redline, W. Henry Boom	55
18	Regulation of Interleukin‐12 by Interleukin‐10, Transforming Growth Factor‐β, Tumor Necrosis Factor‐α, and Interferon‐γ in Human Monocytes Infected withMycobacterium tuberculosisH37Ra 1998 ·The Journal of Infectious Diseases ·Scott A. Fulton, Janet V. Cross, Zahra Toossi, W. Henry Boom	72
19	TREATMENT OF ALCOHOLIC HEPATITIS 1998 ·Clinics in Liver Disease ·Scott A. Fulton, Arthur J. McCullough	7
20	Modulation of IL-12 by transforming growth factor-beta (TGF-beta) in Mycobacterium tuberculosis-infected mononuclear phagocytes and in patients with active tuberculosis. 1997 ·PubMed ·Zahra Toossi, (unknown), (unknown), Scott A. Fulton, (unknown), Christina S. Hirsch	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact